Gunnar Magnus Modee Persson

Gunnar Magnus Modee Persson

Chairman at INITIATOR PHARMA A/S

Net worth: 62 064 $ as of 31/03/2024

64 year
Health Technology
Finance
Electronic Technology

Profile

Gunnar Magnus Modee Persson is the founder of Aerocrine AB, which was founded in 1994.
He currently holds multiple chairman positions at Cantargia AB, Attgeno AB, Galecto Biotech ApS, Karolinska Institutet Information AB, Initiator Pharma A, Hip Health Innovation Platform AB, Galecto Biotech AB, Eir Ventures Partners AB, Gyros AB, Avalo Therapeutics, Inc., Medical Prognosis Institute, Inc., Albumedix A, Mordin AB, Själbådan AB, Gyros Protein Technologies Holding AB, Perma Ventures AB, ADDI Medical AB, P O Persson.
i Lidingö AB, Duomedix AB, Merigen AB, Sls Ventures AB, Avalo, Inc., and Karolinska Institutet.
He has also held former positions as Chief Executive Officer of Karolinska Institutet Holding AB, Chief Executive Officer & Associate Professor of Caerus Consulting AS, Chairman of Scandinavian Life Science Ventures AB, Acting Chairman of Altimmune UK Ltd., Chairman of Karolinska Institutet Innovations AB, Chairman of Karolinska Institutet University Press AB, Chairman of Galecto, Inc., Chairman of Bioworks AB, Director of Ascendx Spine, Inc., Independent Director of Abliva AB, Director-Supervisory Board of Trigen Holdings AG, Director of Healthcap III Sidefund GP AB, Director of Lumavita AG, Director of KCIF Fund Management AB, Director of Medical Prognosis Institute A, Independent Director of Contera Pharma ApS, Independent Director of Karolinska Development AB, Independent Director of Mendus AB, Director of Bio-Works Technologies AB, Director of Karolinska Institutet Support AB, Director of Karolinska Institutet Housing AB, Director of Karolinska Institutet Science Park, Independent Director of Allarity Therapeutics A, Director of Addi Optioner AB, Partner of HealthCap AB, Principal of Odlander, Fredrikson & Co. AB, Gérant of Sanofi Winthrop, and Managing Partner of The Column Group LLC.
He holds a doctorate degree from Karolinska Institutet.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
31/12/2022 190,154 ( 0.10% ) 62 064 $ 31/03/2024

Gunnar Magnus Modee Persson active positions

CompaniesPositionStart
AVALO THERAPEUTICS, INC. Director/Board Member 28/08/2012
CANTARGIA AB Chairman 01/01/2016
INITIATOR PHARMA A/S Chairman 01/01/2016
Chairman -
Chairman 01/01/2018
Director/Board Member 01/10/2015
Medical Prognosis Institute, Inc. Director/Board Member -
Mordin AB Corporate Officer/Principal -
Galecto Biotech AB Chairman -
░░░ ░░░░░░░░ ░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░░
░ ░ ░░░░░░░ ░ ░░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
All active positions of Gunnar Magnus Modee Persson

Former positions of Gunnar Magnus Modee Persson

CompaniesPositionEnd
░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
See the detail of Gunnar Magnus Modee Persson's experience

Training of Gunnar Magnus Modee Persson

Karolinska Institutet Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Gunnar Magnus Modee Persson's experience

Connections

100 +

1st degree connections

51

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies8
ABLIVA AB

Health Technology

CANTARGIA AB

Health Technology

KAROLINSKA DEVELOPMENT AB

Finance

AVALO THERAPEUTICS, INC.

Health Technology

MENDUS AB

Health Technology

BIO-WORKS TECHNOLOGIES AB

Health Technology

INITIATOR PHARMA A/S

Health Technology

GALECTO, INC.

Health Technology

Private companies42

Electronic Technology

Health Technology

Health Technology

Finance

Finance

Health Technology

Miscellaneous

Commercial Services

Finance

Health Technology

Healthcap III Sidefund GP AB

Finance

Finance

Health Services

KCIF Fund Management AB

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Medical Prognosis Institute, Inc.

Health Technology

Karolinska Institutet Information AB

Mordin AB

Consumer Services

Technology Services

Commercial Services

Finance

Finance

Finance

Electronic Technology

Finance

Health Technology

Technology Services

Addi Optioner AB

Galecto Biotech AB

Bioworks AB

Finance

P O Persson i Lidingö AB

Duomedix AB

Merigen AB

Sls Ventures AB

See company connections
  1. Stock Market
  2. Insiders
  3. Gunnar Magnus Modee Persson